Skip to main content

Kcentra FDA Approval History

Last updated by Judith Stewart, BPharm on June 22, 2020.

FDA Approved: Yes (First approved April 29, 2013)
Brand name: Kcentra
Generic name: prothrombin complex concentrate, human
Company: CSL Behring
Treatment for: Reversal of Vitamin K Antagonist (VKA) Anticoagulation

Development timeline for Kcentra

Apr 29, 2013Approval FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.